Diabetic Med:年轻人在大学期间管理1型糖尿病的经历如何?

2018-11-01 MedSci MedSci原创

近日,国际杂志 《Diabetic Med》上在线发表一项关于年轻人在大学期间管理1型糖尿病的经历:英国大学生的全国性的研究。1型糖尿病年轻人患者从学校过渡到大学,对相关护理知识知之甚少。在一项全国调查中,研究人员调查了所有英国大学入读和就读大学的1型糖尿病学生自我护理对糖尿病的影响。研究邀请了1865名年龄在18-24岁之间的英国1型糖尿病大学学生完成一份结构化问卷。使用逻辑回归模型评估人口统计

近日,国际杂志 《Diabetic Med》上在线发表一项关于年轻人在大学期间管理1型糖尿病的经历:英国大学生的全国性的研究。
1型糖尿病年轻人患者从学校过渡到大学,对相关护理知识知之甚少。在一项全国调查中,研究人员调查了所有英国大学入读和就读大学的1型糖尿病学生自我护理对糖尿病的影响。
研究邀请了1865名年龄在18-24岁之间的英国1型糖尿病大学学生完成一份结构化问卷。使用逻辑回归模型评估人口统计学变量和糖尿病变量之间的关联。
本研究共有来自64家医院和37所大学医疗机构的584名(占31%)学生完成了调查问卷。大约62%的人保持常规糖尿病护理,而32%的人转到大学提供者护理。自大学入校以来,63%的人报告糖尿病管理较难,44%的人报告HbA 1c比大学之前的水平较高。在大学,52%的人经常发生低血糖,9.6%的人报告有一次或多次严重低血糖,26%的人经历过糖尿病相关的住院。女学生和改变医疗保健提供者的患者报告血糖控制不佳,紧急住院和频繁发生低血糖的可能性大约是其他人的两倍。女性比男性更容易报告压力[优势比(OR)4.78,95%置信区间(CI)3.19-7.16],疾病(OR 3.48,95%CI 2.06-5.87)和体重管理问题(OR 3.19,95 %CI 1.99-5.11),即自我保健的问题。尽管存在这些困难,91%的受访者从未或很少联系大学支持服务部门以了解他们的糖尿病。
研究量化了大学过渡期间患有1型糖尿病的学生所经历的高风险,特别是女学生和那些转向新的大学医疗保健提供者的人。
原始出处:
本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1970649, encodeId=e22919e06492d, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sun Nov 25 00:08:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760865, encodeId=b8051e60865c7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 23:08:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638825, encodeId=0cf71638825a1, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 30 07:08:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609265, encodeId=c72a160926501, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 03 02:08:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041994, encodeId=7b0410419947b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Nov 01 14:08:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1970649, encodeId=e22919e06492d, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sun Nov 25 00:08:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760865, encodeId=b8051e60865c7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 23:08:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638825, encodeId=0cf71638825a1, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 30 07:08:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609265, encodeId=c72a160926501, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 03 02:08:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041994, encodeId=7b0410419947b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Nov 01 14:08:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1970649, encodeId=e22919e06492d, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sun Nov 25 00:08:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760865, encodeId=b8051e60865c7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 23:08:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638825, encodeId=0cf71638825a1, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 30 07:08:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609265, encodeId=c72a160926501, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 03 02:08:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041994, encodeId=7b0410419947b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Nov 01 14:08:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1970649, encodeId=e22919e06492d, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sun Nov 25 00:08:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760865, encodeId=b8051e60865c7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 23:08:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638825, encodeId=0cf71638825a1, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 30 07:08:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609265, encodeId=c72a160926501, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 03 02:08:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041994, encodeId=7b0410419947b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Nov 01 14:08:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1970649, encodeId=e22919e06492d, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sun Nov 25 00:08:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760865, encodeId=b8051e60865c7, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 23:08:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638825, encodeId=0cf71638825a1, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 30 07:08:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609265, encodeId=c72a160926501, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 03 02:08:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041994, encodeId=7b0410419947b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Thu Nov 01 14:08:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
    2018-11-01 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

NATURE:早期1型糖尿病患者的肠道微生物组成如何?

1型糖尿病(T1D)是一种针对胰岛细胞的自身免疫性疾病,也与复杂的遗传和环境因素,以及病人暴露和肠道菌群相关。经确定病毒感染和更广泛的肠道菌群失调为潜在的原因或促成因素。然而,目前研究还没有发现能够预测胰岛自身免疫或T1D的微生物组成或功能触发器。 在本研究中,研究人员收集了783名婴儿(非西班牙)的近11000个粪便样本,对发展为T1D儿童的早期肠道菌群进行了分析。 研究发现对照组儿

Diabetic Med:1型糖尿病患儿父母对低血糖的意识和恐惧

近日,国际杂志 《Diabetic Med》上在线发表一项关于1型糖尿病患儿父母对低血糖的警觉和意识的荷兰MILES青年糖尿病结果的研究结果。研究目的是确定患有1型糖尿病的儿童(4-18岁)的父母对低血糖的恐惧的社会人口学和临床相关性,并调查父母对低血糖,意识和意识养育的恐惧之间的关系。从荷兰MILES青年糖尿病横断面数据集截取社会人口统计学,自我报告的临床和心理学数据。调查问卷包括低血糖恐惧调查

病例分享:渴络欣胶囊治疗1型糖尿病患者慢性肾脏病1例

患者,女,30岁,因“慢性肾功能衰竭,1型糖尿病,肺部感染”于2018年5月16日收于我科。16年前经相关检查明确诊断为“1型糖尿病”,1年前发现血压升高,最高血压160/110 mmHg,未重视,未随访血压。1年前因怀孕发现血肌酐286 μmol/L,终止妊娠后行肾活检,明确诊断为“慢性肾功能不全、CKD Ⅳ期,1型糖尿病、糖尿病肾病、肾性贫血、肾性高血压”。患者自诉无家族史,否认冠心病史、传染

Diabetic Med:北京和汕头1型糖尿病患者的年龄分布和代谢紊乱状况如何?

近日,国际杂志 《Diabetic Med》上在线发表一项关于北京和汕头1型糖尿病患者的年龄分布和代谢紊乱的横断面研究。分析研究了1型糖尿病患者的年龄特征是否与一般人群的年龄特征不同,并研究中国1型糖尿病患者代谢紊乱的临床特征。 研究人员从医院记录,住院病房和门诊病历依次登记了849名患有1型糖尿病的人。通过面对面访谈,医疗记录和静脉血液样本收集数据。2011年北京人口普查数据用于提供一般人

病例分享:渴络欣胶囊治疗1型糖尿病患者慢性肾脏病1例

16年前经相关检查明确诊断为“1型糖尿病”,1年前发现血压升高,最高血压160/110 mmHg,未重视,未随访血压。1年前因怀孕发现血肌酐286 μmol/L,终止妊娠后行肾活检,明确诊断为“慢性肾功能不全、CKD Ⅳ期,1型糖尿病、糖尿病肾病、肾性贫血、肾性高血压”。

Diabetic Med:青少年心理健康咨询和社会经济地位低下与成年早期1型糖尿病并发症相关

近日,国际杂志 《Diabetic Med》上在线发表一项关于青少年心理健康咨询就诊和社会经济地位低下与成年早期1型糖尿病并发症相关:基于人群的队列研究。研究目的是确定青春期后期心理健康就诊和社会经济状况与成年早期死亡和急性和慢性糖尿病并发症风险之间的关系。 研究人员在加拿大安大略省使用链接的管理数据库(ñ=8491)进行了基于人群的队列研究,包括在1999年1月和2015年3月间度过其20